Initiated the Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (HS) and the Phase 3 ...

The China cell culture media bags market is set for robust expansion, with projections indicating it will reach USD 198.1 million by 2025 and grow at a 4.7% CAGR, exceeding USD 313.6 million by ...

Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to stimulate immune-mediated eradication of tumors.